Verify patient identity, obtain informed consent, review relevant imaging (e.g., ultrasound or MRI), and confirm absence of local infection or systemic contraindications such as uncontrolled diabetes or allergy to corticosteroids.
Apply ice pack to the site for 15-20 minutes. Advise the patient to avoid strenuous overhead activity for 48 hours. Monitor for immediate post-injection flare, which typically subsides within 24-48 hours. Discharge immediately.
Comprehensive Clinical Guide: Subacromial Bursa Injection (Corticosteroid)
1. Introduction and Overview
The subacromial bursa is a thin, fluid-filled sac situated between the rotator cuff tendons (specifically the supraspinatus) and the acromion process of the scapula. Its primary function is to reduce friction during shoulder abduction and rotation. When this bursa becomes inflamed—a condition known as subacromial bursitis—it leads to significant pain, restricted range of motion, and functional impairment.
A Subacromial Bursa Injection (SBI) involving a corticosteroid is a minimally invasive clinical procedure designed to deliver a potent anti-inflammatory agent directly into the subacromial space. This intervention is a cornerstone of conservative orthopedic management, bridging the gap between physical therapy and surgical intervention. By reducing localized inflammation, the procedure facilitates pain relief, allowing for more effective engagement in rehabilitative exercises.
2. Mechanism of Action and Technical Specifications
The Pharmacology of Corticosteroids
Corticosteroids (such as triamcinolone acetonide, methylprednisolone, or betamethasone) work by inhibiting the production of inflammatory mediators. They exert their effects through:
* Inhibition of Phospholipase A2: This prevents the release of arachidonic acid, effectively blocking the synthesis of prostaglandins and leukotrienes.
* Downregulation of Cytokines: They decrease the expression of pro-inflammatory cytokines such as IL-1, IL-6, and TNF-alpha.
* Stabilization of Lysosomal Membranes: This prevents the release of destructive enzymes from neutrophils into the surrounding tissues.
Anatomical Targeting
The subacromial space is a confined anatomical region. Precision is critical; the goal is to place the injectate within the bursa itself to avoid intratendinous injection, which can weaken the rotator cuff collagen matrix. Modern clinical practice increasingly utilizes ultrasound guidance to ensure the needle tip is correctly positioned between the acromion and the supraspinatus tendon.
3. Clinical Indications and Usage
The decision to perform an SBI is based on clinical presentation, physical examination, and imaging findings.
Primary Indications
- Subacromial Bursitis: Acute or chronic inflammation confirmed via clinical tests (e.g., Neer’s test, Hawkins-Kennedy test).
- Rotator Cuff Tendinopathy: Often co-exists with bursitis.
- Shoulder Impingement Syndrome: Used to reduce edema so the patient can tolerate physical therapy.
- Adhesive Capsulitis (Early Stage): Where bursal inflammation contributes to the "frozen" phase of the condition.
Clinical Selection Criteria
| Criteria | Description |
|---|---|
| Pain Duration | Typically > 6 weeks of persistent pain unresponsive to NSAIDs. |
| Physical Findings | Positive impingement signs; pain with overhead reaching. |
| Imaging | MRI or Ultrasound showing bursal thickening or fluid distention. |
| Patient Goal | Desire to avoid or delay surgical intervention (e.g., acromioplasty). |
4. Pre-Operative Preparation
Preparation is vital to minimize infection risk and ensure patient comfort.
- Patient Consent: Review the risks, benefits, and alternatives with the patient.
- Safety Checklist: Confirm no active infection (systemic or local), no coagulopathy, and no allergy to corticosteroids or local anesthetics (e.g., lidocaine).
- Positioning: The patient is typically seated with the arm slightly extended or in a neutral position, often with the hand resting on the ipsilateral hip to open the subacromial space.
- Sterile Field: The injection site must be cleaned with chlorhexidine or povidone-iodine. A "no-touch" technique is strictly observed.
5. The Procedure: Step-by-Step
Step 1: Anesthesia
A local anesthetic (1-2% lidocaine or bupivacaine) is infiltrated into the skin and subcutaneous tissue.
Step 2: Needle Placement
Using a posterior, lateral, or anterior approach (posterior is most common), a 22-25 gauge needle is advanced toward the subacromial space. If using ultrasound, the clinician visualizes the needle trajectory to avoid the acromion and the tendon surface.
Step 3: Aspiration
Before injection, attempt to aspirate. If fluid is obtained, it may be sent for analysis (e.g., if infection or crystal arthropathy is suspected).
Step 4: Injection
The corticosteroid mixture (often combined with a local anesthetic for immediate diagnostic confirmation) is injected slowly. There should be no resistance; if resistance is felt, the needle may be within the tendon substance and must be repositioned.
Step 5: Post-Injection Assessment
The needle is withdrawn, and the site is dressed. The patient is asked to perform a gentle overhead movement to assess immediate pain relief (the "diagnostic" component).
6. Post-Operative Recovery and Protocol
- Immediate Post-Op: Patients should avoid strenuous overhead activities for 24–48 hours.
- The "Steroid Flare": Patients should be warned about a temporary increase in pain (lasting 24–72 hours) as the medication crystallizes.
- Rehabilitation: Physical therapy should be initiated or resumed within 3–5 days to maximize the "window of opportunity" created by the pain reduction.
- Monitoring: Patients are typically re-evaluated 4–6 weeks post-injection to determine the need for further intervention.
7. Risks and Potential Complications
While generally safe, clinicians must be aware of potential adverse outcomes:
* Infection (Septic Bursitis): Rare, but serious. Requires urgent drainage and antibiotics.
* Tendon Rupture/Atrophy: Repeated injections (more than 3–4 per year) can degrade the collagen in the rotator cuff, increasing the risk of full-thickness tears.
* Skin Hypopigmentation/Atrophy: If the steroid is injected too superficially into the subcutaneous fat.
* Systemic Effects: Temporary hyperglycemia (especially in diabetic patients), facial flushing, or menstrual irregularities.
* Post-Injection Flare: A transient inflammatory response to the crystalline steroid.
8. Alternative Treatments
If an SBI fails to provide relief, the following alternatives should be considered:
1. Physical Therapy (Focused): Scapular stabilization and rotator cuff strengthening.
2. Platelet-Rich Plasma (PRP): Emerging biological therapy for chronic tendinopathy.
3. Hyaluronic Acid Injection: Viscosupplementation, though less common for bursitis than for joints.
4. Surgical Intervention: Arthroscopic subacromial decompression (ASD) for persistent impingement.
9. Frequently Asked Questions (FAQ)
1. How long does the pain relief last?
Results vary. Some patients experience relief for months, while others may only see a few weeks of improvement. It is not a cure; it is a tool to facilitate rehabilitation.
2. How many injections can I have?
Standard clinical practice generally limits injections to 3–4 per year to minimize the risk of tendon weakening and cartilage damage.
3. Does it hurt?
The local anesthetic stings briefly, but the actual injection is usually described as more "pressurized" than painful.
4. Will I be able to drive home?
Yes, most patients can drive, provided they are not under the influence of sedation and have full range of motion.
5. What if I am diabetic?
Corticosteroids can cause a temporary spike in blood glucose levels. Diabetics should monitor their blood sugar closely for 48 hours post-injection.
6. Is ultrasound guidance necessary?
While not strictly mandatory, studies indicate that ultrasound-guided injections are significantly more accurate than "blind" landmark-guided injections.
7. What is the "steroid flare"?
This is a common reaction where the area feels more sore after the anesthetic wears off, usually lasting 24–72 hours. Ice packs usually manage this effectively.
8. Can this cause a rotator cuff tear?
Excessive or poorly placed injections can weaken the tendon. This is why adherence to total annual limits and precise needle placement is vital.
9. How soon can I return to sports?
Light activities can resume within a few days. High-impact overhead sports should wait until the patient has completed a prescribed physical therapy protocol.
10. What if the injection doesn't work?
If there is zero relief, it may suggest that the pain source is not the bursa (e.g., cervical radiculopathy or glenohumeral joint pathology) or that the injection missed the target.
10. Summary Table: Clinical Success Factors
| Factor | Impact on Outcome |
|---|---|
| Accurate Diagnosis | High (Injection will not fix a full-thickness tear) |
| Ultrasound Guidance | High (Ensures intra-bursal delivery) |
| Concurrent PT | Critical (Prevents recurrence) |
| Patient Age | Moderate (Younger patients may have better biological healing) |
| Frequency | Moderate (Over-utilization leads to degenerative effects) |
Disclaimer
This guide is for educational purposes for healthcare professionals and patients. It does not replace the professional judgment of an orthopedic surgeon or physical medicine and rehabilitation specialist. Always consult with a qualified clinician regarding your specific medical condition.
